Late Breaking Abstract - Reslizumab vs benralizumab in patients with inadequately controlled asthma: a Bayesian network meta-analysis

@inproceedings{Casale2017LateBA,
  title={Late Breaking Abstract - Reslizumab vs benralizumab in patients with inadequately controlled asthma: a Bayesian network meta-analysis},
  author={Thomas B. Casale and Laura Mesana and Maud Pacou and Ga{\"e}Lle Farge and Shawn X. Sun and Mario Castro},
  year={2017}
}

Topics from this paper.

Similar Papers

Loading similar papers…